Ferring Sues Apotex Over DDAVP Generic
Ferring sued Ontario-based Apotex Inc. in U.S. District Court for the District of New Jersey last week, alleging infringement of the patent used for the tablet version of its desmopressin drug called DDAVP.
Ferring was alerted to generic drug maker Apotex’s intentions when it completed an Abbreviated New Drug Application in July, requesting permission from the U.S. Food and Drug Administration to manufacture and...
Already a subscriber? Click here to login